Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Designing Polyelectrolyte Microneedles Based on Borylated Poly(β-aminoester) Polymers To Enhance Transdermal pH-Controlled Delivery of Nucleic Acids

  • Gonzalez-Saenz, Patricia
  • Cosialls, Raúl
  • Texidó Bartes, Robert
  • Dols-Perez, Aurora
  • Cuenca, Ana Belen
  • Borrós, Salvador
  • Fornaguera, Cristina
The use of transdermal delivery for nucleic acidadministration is an interesting approach to overcoming limitations ofsystemic administration routes, such as first-pass effects, the painfulneedle injection, or their poor biodistribution. Thus, the use of amicroneedle-based patch could represent a turning point for nucleic aciddelivery, thanks to the possibility of self-administration of the actives in apainless and easy procedure. However, the design of transdermal systemswith a higher degree of precision release is a clear need that has not beenfully resolved. Committed to tackling this challenge, we present here amicroneedle patch that involves a smart delivery system supported by thewell-established ability of boronic acid to interact with carbohydrates in apH-dependent manner. This system builds up a multilayer structure overa solid microneedle platform whose surface has been modified toimmobilize glucosamine units that are able to interact with anoligopeptide-end terminated poly(β-aminoester) that presents a 4-carboxy-3-fluorophenylboronic acid (Bor-pBAE). Thus,sequential layers of the Bor-pBAE and plasmid DNA have been assembled, thanks to the ability of the polymer to interact withthe nucleic acid at a basic pH and then gradually release the plasmid under two different conditions of pH (the physiological pH =7.4 and the acidic pH = 5.1). We set up the design and implementation of this first proof of concept while demonstratingmicroneedles' safety and functionality. Additionally, we have shown the efficacy of the construct to express the encoded genes inmodel cell lines. In conclusion, we have established the basis to confirm that this generation of borylated poly(β-aminoesters) holdsgreat promise as a transdermal local nucleic acid delivery system., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Polymeric nanoparticles for liver-targeted pituitary tumor-transforming gene 1 silencing in rats with chronic liver disease

  • Perramón Corominas, Meritxell
  • Navalón López, María
  • Fernández Varo, Guillermo
  • Casals Mercadal, Gregori
  • Faneca Farrés, Joana
  • Macias-Herranz, Manuel
  • Boix, Loreto
  • Fundora Suarez, Yiliam
  • Morales-Ruiz, Manuel
  • Garcia-Villoria, Judit
  • Fornaguera, Cristina
  • Borrós, Salvador
  • Jiménez, Wladimiro
Pituitary tumor transforming gene 1 (Pttg1) is upregulated in cirrhosis and hepatocarcinoma (HCC). We assessed the therapeutic effect of liver-targeted Pttg1 siRNA Retinol (Ret) pBAE nanoparticles (NPs) to treat these disturbances. Fibrosis was induced in Wistar rats by carbon tetrachloride inhalation and HCC by diethylnitrosamine injection. Ret pBAE NPs accumulated in hepatic tissue, close to zones positive for αSMA staining. Pttg1 interference increased mean arterial pressure, reduced portal hypertension and decreased collagen accumulation and inflammatory infiltrate in fibrotic rats. In HCC rats, Pttg1 silencing reduced liver to body weight ratio and hepatic proliferation and increased hepatic ATP production and serum glucose. This therapy effectively mitigated liver fibrosis and HCC progression in experimental models. The feasibility of this treatment was also demonstrated in human derived hepatic stellate cells and in ex vivo human cirrhotic livers underscoring the therapeutic potential of Pttg1 siRNA Ret pBAE NPs in addressing liver fibrosis and HCC., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Designing Polyelectrolyte Microneedles Based on Borylated Poly(β-aminoester) Polymers To Enhance Transdermal pH-Controlled Delivery of Nucleic Acids

  • Gonzalez-Saenz, Patricia
  • Cosialls, Raúl
  • Texidó Bartes, Robert
  • Dols-Perez, Aurora
  • Cuenca, Ana Belen
  • Borrós, Salvador
  • Fornaguera, Cristina
The use of transdermal delivery for nucleic acidadministration is an interesting approach to overcoming limitations ofsystemic administration routes, such as first-pass effects, the painfulneedle injection, or their poor biodistribution. Thus, the use of amicroneedle-based patch could represent a turning point for nucleic aciddelivery, thanks to the possibility of self-administration of the actives in apainless and easy procedure. However, the design of transdermal systemswith a higher degree of precision release is a clear need that has not beenfully resolved. Committed to tackling this challenge, we present here amicroneedle patch that involves a smart delivery system supported by thewell-established ability of boronic acid to interact with carbohydrates in apH-dependent manner. This system builds up a multilayer structure overa solid microneedle platform whose surface has been modified toimmobilize glucosamine units that are able to interact with anoligopeptide-end terminated poly(β-aminoester) that presents a 4-carboxy-3-fluorophenylboronic acid (Bor-pBAE). Thus,sequential layers of the Bor-pBAE and plasmid DNA have been assembled, thanks to the ability of the polymer to interact withthe nucleic acid at a basic pH and then gradually release the plasmid under two different conditions of pH (the physiological pH =7.4 and the acidic pH = 5.1). We set up the design and implementation of this first proof of concept while demonstratingmicroneedles' safety and functionality. Additionally, we have shown the efficacy of the construct to express the encoded genes inmodel cell lines. In conclusion, we have established the basis to confirm that this generation of borylated poly(β-aminoesters) holdsgreat promise as a transdermal local nucleic acid delivery system., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Polymeric nanoparticles for liver-targeted pituitary tumor-transforming gene 1 silencing in rats with chronic liver disease

  • Perramón Corominas, Meritxell
  • Navalón López, María
  • Fernández Varo, Guillermo
  • Casals Mercadal, Gregori
  • Faneca Farrés, Joana
  • Macias-Herranz, Manuel
  • Boix, Loreto
  • Fundora Suarez, Yiliam
  • Morales-Ruiz, Manuel
  • Garcia-Villoria, Judit
  • Fornaguera, Cristina
  • Borrós, Salvador
  • Jiménez, Wladimiro
Pituitary tumor transforming gene 1 (Pttg1) is upregulated in cirrhosis and hepatocarcinoma (HCC). We assessed the therapeutic effect of liver-targeted Pttg1 siRNA Retinol (Ret) pBAE nanoparticles (NPs) to treat these disturbances. Fibrosis was induced in Wistar rats by carbon tetrachloride inhalation and HCC by diethylnitrosamine injection. Ret pBAE NPs accumulated in hepatic tissue, close to zones positive for αSMA staining. Pttg1 interference increased mean arterial pressure, reduced portal hypertension and decreased collagen accumulation and inflammatory infiltrate in fibrotic rats. In HCC rats, Pttg1 silencing reduced liver to body weight ratio and hepatic proliferation and increased hepatic ATP production and serum glucose. This therapy effectively mitigated liver fibrosis and HCC progression in experimental models. The feasibility of this treatment was also demonstrated in human derived hepatic stellate cells and in ex vivo human cirrhotic livers underscoring the therapeutic potential of Pttg1 siRNA Ret pBAE NPs in addressing liver fibrosis and HCC., info:eu-repo/semantics/publishedVersion